People news

ImmunoGen, a biopharma that develops targeted anticancer therapeutics, has appointed James O'Leary as VP, chief medical officer.

November 11, 2008

5:41 pm

ImmunoGen, a biopharma that develops targeted anticancer therapeutics, has appointed James O’Leary as VP, chief medical officer. O’Leary will lead the clinical development of ImmunoGen’s product candidates. ImmunoGen has collaborated with Genentech, Sanofi-Aventis, Biogen Idec, Bayer HealthCare and Amgen.

Cynvec LLC, a biopharma focused on developing cancer therapies that harness the apoptotic ability of the Sindbis viral vector, has appointed Frank Stonebanks as president and CEO, effective immediately. Stonebanks has previously worked at Johnson & Johnson and led the oncology biologics business unit at Centocor.

From Our Partners

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.

A Big C Shift: Rebranding cancer to reflect advances in oncology

Partner Content

A Big C Shift: Rebranding cancer to reflect advances in oncology

Pivoting people’s perception of the disease to match the realities of treatment.